Case report: Ruxolitinib as first-line therapy for secondary hemophagocytic lymphohistiocytosis in patients with AIDSXiang Liu, Biao Zhu, Ying Huang et al.|Frontiers in Immunology|2022Cited by 9
Lenalidomide potentially reduced the level of cell- associated HIV RNA and improved persistent inflammation in patients with HIV-associated cryptococcal meningitis a pilot studyXiang Liu, Biao Zhu, Xueling Zhu et al.|Frontiers in Cellular and Infection Microbiology|2022Cited by 4
Distinct Lipidomic Profiles between People Living with HIV Treated with E/C/F/TAF or B/F/TAF: An Open-Label Prospective Cohort StudyZhikai Wan, Biao Zhu, Guanjing Lang et al.|Infectious Diseases and Therapy|2024Cited by 4
Efficacy and safety of lenalidomide in HIV-associated cryptococcal meningitis patients with persistent intracranial inflammation: an open-label, single-arm, prospective interventional studyZhikai Wan, Biao Zhu, Xueling Zhu et al.|Journal of Neuroinflammation|2023Cited by 3
Safety and efficacy of PD-1 inhibitors in HIV-infected patients with severe comorbidities: a prospective observational cohort studyXueling Zhu, Biao Zhu, Junwei Su et al.|Chinese Medical Journal|2023Cited by 1